Farmakoekonomikā izmantojamo metožu un rādītāju noteikšanai nepieciešamo datu iegūšanas iespējas Latvijā

Considering the topicality of the issue and the large field of potential application for the introduction of pharmacoeconomic knowledge in the stages where it has not yet been introduced, there is an acute need for such investigation. So, the author has chosen to study the possibilities for getting necessary data for conducting pharmacoeconomic assessments in Latvia. The availability of appropriate and valid data is one of the most important preconditions for successful pharmacoeconomic assessment and decisionmaking process. The topic of the study does not comprise all areas of pharmacoeconomic methodology but rather limits itself to studying the classic economic evaluation methods and some of the indicators widely and rarely used in the pharmacoeconomic assessment. During the research the author has come to the
following conclusions and recommendations:
• the pharmacoeconomic assessment in Latvia should be conducted in an analytical perspective of the society as a whole, considered in the context of national economy by calculating the costs for the state arising from an employee’s absence from work due to sickness, reduction of work capacity or early death;
• taking into account the insufficient use of the productivity cost calculations in practice the author offers a modified formula that would allow for obtaining more precise data according to the Latvian scale;
• the significant prospect in which the problem should be examined is not dedicated to the availability of the data for conducting pharmacoeconomic assessment, but rather the lack of Latvian specialists in pharmacoeconomics and health economics who would identify, analyse and interpret the data.